VIDEO: A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC
In this video, renowned oncologist Dr. Joyce O’Shaughnessy speaks about how treatment outcomes may vary for patients with HR+, HER2- MBC depending on the breast cancer subtype and the underlying disease heterogeneity.
Date of Last Review: April 22, 2024
Document Number: VV-MED-153055
Are you satisfied with this content?